QuidelOrtho Corporation (QDEL) Fair Value 2026

QDEL · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.8 /10

32 fundamental signals · 5 models active

Value Trap Risk

LOW (38/100)

Quick Summary — As of 2026-08-27, QuidelOrtho Corporation (QDEL) trades at $15.32, versus a $43.29 median fair value across its 5 active models — 182.6% above the current price. QOC: 5.8/10. Value Trap Risk: 38/100 (LOW). 5/13 models active.

Key Facts

Ticker
QDEL
Price
$15.32
Quality Score
5.8/10
Value Trap Risk
38/100
Models Active
5/13
Last Updated
Strength: CUCE Ensemble suggests +173.5% upside with 14% confidence
Risk: Limited model coverage (5/13) may reduce confidence

Is QuidelOrtho Corporation (QDEL) Undervalued or Overvalued in 2026?

According to CirclFi’s 5-model valuation engine, QuidelOrtho Corporation (QDEL) appears undervalued as of : the median of 5 independent fair value estimates is $43.29, 182.6% above the current price of $15.32. Estimates range from $11.46 to $59.24. QDEL scores 5.8/10 on fundamental quality and 38/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. QDEL’s +182.6% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy QuidelOrtho Corporation Stock in 2026? →

What Fair Value Does Each Model Give QDEL?

5 Intrinsic Value Models vs. Current Price ($15.32)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $41.91 +173.5%
Intrinsic · High Conviction
 $11.46 -25.2%
Unlock the Full Matrix

Access 3 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 5 Models →

Cancel anytime · No contracts · Instant access

What Is QDEL's Fair Value Range?

Spread across 5 independent models · $11.46 to $59.24

CirclFi's 5 active models place QuidelOrtho Corporation (QDEL) between $11.46 and $59.24 per share, a spread of 110% of the median. The median of that range — $43.29 — is the fair value CirclFi publishes for QDEL, against a current price of $15.32.

Low · ML-RIVHigh · PWERM
$11.46median $43.29$59.24
Where the range comes from
Most bearish modelML Residual Income$11.46
Most bullish modelPWERM$59.24
Model agreement4 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for QDEL. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on QDEL, not a CirclFi price target. How each model works →

What Is QuidelOrtho Corporation (QDEL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for QuidelOrtho Corporation. Trading at $15.32 against an estimated intrinsic value of $43.29, 4 of 5 active models flag meaningful upside of +182.6% at the median. The most optimistic model, PWERM, places fair value at $59.24 (+286.7%), while ML-RIV — the most conservative — estimates $11.46 (-25.2%). This +311.9% gap reflects genuine analytical uncertainty about QuidelOrtho Corporation's intrinsic worth.

What Do the Models Say About QDEL?

5 of 13 models are currently active for QDEL. Of these, 4 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for QDEL is $43.29 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does QDEL Rank in Medical Devices?

Among 157 Medical Devices stocks, QDEL ranks #96 by Quality of Company score. CirclFi's QOC score of 5.8/10 evaluates 32 fundamental signals. A score of 5.8 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to pharmaceutical industry businesses. For QuidelOrtho Corporation, metrics like pipeline depth and stage distribution provide important context that general-purpose valuation models may underweight.

Is QDEL a Value Trap?

CirclFi's Value Trap algorithm assigns QDEL a score of 38/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

5 of 13 models are active for QuidelOrtho Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, QuidelOrtho Corporation scores 5.8 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +311.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every QDEL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across QDEL's 5 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy QuidelOrtho Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

OWLTOwlet, Inc.QOC 5.8ADMTADM Tronics Unlimited, Inc.QOC 5.8XAIRBeyond Air, Inc.QOC 5.8CODXCo-Diagnostics, Inc.QOC 5.8LABStandard BioTools Inc.QOC 5.9CVCapsoVision, Inc.QOC 5.7POASPhaos Technology Holdings (CaymQOC 4.5INMDInMode Ltd.QOC 8.5NEOGNeogen CorporationQOC 6.9IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: OWLT · ADMT · XAIR · CODX · LAB · CV · POAS · INMD · NEOG · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to QDEL?

7 companies across all industries closest to QDEL’s Quality of Company score of 5.8/10.

MARAMARA Holdings, Inc.QOC 5.8CDChaince Digital Holdings Inc.QOC 5.8AURAAura Biosciences, Inc.QOC 5.8NNNextNav Inc.QOC 5.8EHSIElite Health Systems Inc.QOC 5.8MRVIMaravai LifeSciences Holdings, Inc.QOC 5.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MARA · CD · AURA · NN · EHSI · MRVI · NVDA

Where Does QDEL Sit in CirclFi's Medical Devices Rankings?

QDEL is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About QuidelOrtho Corporation’s Valuation?

What is QuidelOrtho Corporation's intrinsic value in 2026?

CirclFi puts QuidelOrtho Corporation (QDEL)'s intrinsic value at $43.29 — the median of 5 independent model estimates as of 2026-08-27, ranging from $11.46 to $59.24. The Quality of Company score is 5.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is QDEL overvalued or undervalued right now?

At $15.32, 4 of 5 active models suggest QDEL may be undervalued, while 1 indicate potential overvaluation. The median of all 5 fair value estimates is $43.29, 182.6% above the current price of $15.32 — a consensus view that QDEL is undervalued. The assessment depends on which methodology best fits QuidelOrtho Corporation's business model in Medical Devices.

What does a Quality of Company score of 5.8 mean for QDEL?

QuidelOrtho Corporation's QOC of 5.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on QDEL?

CirclFi analyzes QDEL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 5 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on QDEL?

Of the 5 models currently active on QDEL, PWERM is the most bullish at $59.24 per share, and ML Residual Income is the most bearish at $11.46. CirclFi's published fair value for QDEL is the median of that range, $43.29, not either extreme. The gap between the two ends equals 110% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is QDEL a value trap in 2026?

QuidelOrtho Corporation's Value Trap score is 38/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 5-model valuation engine, QuidelOrtho Corporation (QDEL) has a median fair value of $43.29 — 182.6% above the current price of $15.32 — as of 2026-08-27.” Source: circlfi.com/stock/QDEL/ · Methodology
Primary sources for this QDEL valuation
  • Financial statements: QuidelOrtho Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001906324) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for QDEL as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 5 mathematical frameworks give you clarity on QDEL.

Unlock All 5 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for QDEL Unlock All 5 — $39/mo